What is FibroBiologics, Inc. Common Stock's Market Cap?

FibroBiologics, Inc. Common Stock's Market Cap is $12.0M, based on as-reported figures from SEC (XBRL) filings.

What is FibroBiologics, Inc. Common Stock's Net Income (TTM)?

FibroBiologics, Inc. Common Stock's Net Income (TTM) is -$18.1M, based on as-reported figures from SEC (XBRL) filings.

What is FibroBiologics, Inc. Common Stock's EBITDA?

FibroBiologics, Inc. Common Stock's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.

What is FibroBiologics, Inc. Common Stock's Diluted EPS (TTM)?

FibroBiologics, Inc. Common Stock's Diluted EPS (TTM) is -2.72, based on as-reported figures from SEC (XBRL) filings.

FibroBiologics, Inc. Common Stock (FBLG) Financial Statements

FibroBiologics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01K4MB4V6

XNAS · usd

1.80▲ 0.09 (5.26%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.71

Day's Range1.62 – 1.82

52-Week Range0.19 – 4.18

Volume165.8K

Avg Volume293.5K

Share Statistics

Shares Outstanding

Employees15

ExchangeXNAS

Listed2024-01-31

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about FibroBiologics, Inc. Common Stock (FBLG)

What is FibroBiologics, Inc. Common Stock's Market Cap?: FibroBiologics, Inc. Common Stock's Market Cap is $12.0M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's Net Income (TTM)?: FibroBiologics, Inc. Common Stock's Net Income (TTM) is -$18.1M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's EBITDA?: FibroBiologics, Inc. Common Stock's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.
What is FibroBiologics, Inc. Common Stock's Diluted EPS (TTM)?: FibroBiologics, Inc. Common Stock's Diluted EPS (TTM) is -2.72, based on as-reported figures from SEC (XBRL) filings.